Rocket


Overview
Financials
News + Filings
Key Docs
Charts
Ownership
Insiders





All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other


Tags
Director comp.
Appointed director
Inv. presentation
Quarterly results

Amneal Pharmaceuticals, Inc. (AMRX) Create: Alert

All | News | Filings
Date FiledTypeDescription
08/15/2023 4 BOYER ANDREW S (Executive Vice President) has filed a Form 4 on Amneal Pharmaceuticals, Inc.
Txns: Sold 29,302 shares @ $4.1267, valued at $120.9k
08/11/2023 144/A Form 144/A - Report of proposed sale of securities: [Amend]
08/11/2023 144 Form 144 - Report of proposed sale of securities:
08/11/2023 144 Form 144 - Report of proposed sale of securities:
08/09/2023 S-8 Form S-8 - Securities to be offered to employees in employee benefit plans:
08/08/2023 10-Q Quarterly Report for the period ended June 30, 2023
08/04/2023 8-K Quarterly results
Docs: "AMNEAL REPORTS SECOND QUARTER 2023 FINANCIAL RESULTS"
08/01/2023 4 Form 4 - Statement of changes in beneficial ownership of securities:
07/05/2023 4 BOYER ANDREW S (Executive Vice President) has filed a Form 4 on Amneal Pharmaceuticals, Inc.
Txns: Paid exercise price by delivering 11,571 shares @ $3.1, valued at $35.9k
Exercised 23,095 restricted stock units @ $0
05/19/2023 8-K Other Events, Financial Statements and Exhibits  Interactive Data
Docs: "UNITED STATES SECURITIES AND EXCHANGE COMMISSION",
"Notice of Pendency of Settlement of Derivative Action"
05/12/2023 8-K Submission of Matters to a Vote of Security Holders  Interactive Data
05/11/2023 4 MEISTER PAUL M (Director) has filed a Form 4 on Amneal Pharmaceuticals, Inc.
Txns: Granted 107,034 restricted stock units @ $0
Exercised 112,179 restricted stock units @ $0
05/11/2023 4 Alva Emily Peterson (Director) has filed a Form 4 on Amneal Pharmaceuticals, Inc.
Txns: Granted 76,453 restricted stock units @ $0
Exercised 80,128 restricted stock units @ $0
05/11/2023 4 Autor Deborah M. (Director) has filed a Form 4 on Amneal Pharmaceuticals, Inc.
Txns: Granted 76,453 restricted stock units @ $0
05/11/2023 4 Kiely John (Director) has filed a Form 4 on Amneal Pharmaceuticals, Inc.
Txns: Granted 76,453 restricted stock units @ $0
Exercised 80,128 restricted stock units @ $0
05/11/2023 4 Yanai Shlomo (Director) has filed a Form 4 on Amneal Pharmaceuticals, Inc.
Txns: Granted 76,453 restricted stock units @ $0
Exercised 80,128 restricted stock units @ $0
05/11/2023 4 BUCHI J KEVIN (Director) has filed a Form 4 on Amneal Pharmaceuticals, Inc.
Txns: Granted 76,453 restricted stock units @ $0
Exercised 80,128 restricted stock units @ $0
05/11/2023 4 Patel Gautam (Director) has filed a Form 4 on Amneal Pharmaceuticals, Inc.
Txns: Granted 76,453 restricted stock units @ $0
Exercised 80,128 restricted stock units @ $0
05/11/2023 4 George Jeffrey P. (Director) has filed a Form 4 on Amneal Pharmaceuticals, Inc.
Txns: Granted 76,453 restricted stock units @ $0
Exercised 80,128 restricted stock units @ $0
05/11/2023 4 Nark Ted C (Director) has filed a Form 4 on Amneal Pharmaceuticals, Inc.
Txns: Granted 76,453 restricted stock units @ $0
Exercised 80,128 restricted stock units @ $0
05/09/2023 10-Q Quarterly Report for the period ended March 31, 2023
05/05/2023 8-K Quarterly results
Docs: "AMNEAL REPORTS FIRST QUARTER 2023 FINANCIAL RESULTS"
04/17/2023 8-K Quarterly results
03/24/2023 DEFA14A Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
03/24/2023 DEF 14A Form DEF 14A - Other definitive proxy statements:
03/14/2023 4 Konidaris Tasos (Executive Vice President & CFO) has filed a Form 4 on Amneal Pharmaceuticals, Inc.
Txns: Exercised 87,719 restricted stock units @ $0
03/07/2023 4 Shah Nikita (Executive Vice President) has filed a Form 4 on Amneal Pharmaceuticals, Inc.
Txns: Paid exercise price by delivering 18,064 shares @ $1.92, valued at $34.7k
Exercised 36,232 restricted stock units @ $0
Granted 183,486 restricted stock units @ $0
Granted 366,972 options to buy @ $0
03/07/2023 4 Konidaris Tasos (Executive Vice President & CFO) has filed a Form 4 on Amneal Pharmaceuticals, Inc.
Txns: Exercised 45,289 restricted stock units @ $0
Granted 229,358 restricted stock units @ $0
Granted 458,716 options to buy @ $0
03/07/2023 4 Patel Chintu (Co-CEO) has filed a Form 4 on Amneal Pharmaceuticals, Inc.
Txns: Granted 733,944 options to buy @ $0
03/07/2023 4 Patel Chirag K. (President & Co-CEO) has filed a Form 4 on Amneal Pharmaceuticals, Inc.
Txns: Granted 733,944 options to buy @ $0
03/07/2023 4 BOYER ANDREW S (Executive Vice President) has filed a Form 4 on Amneal Pharmaceuticals, Inc.
Txns: Paid exercise price by delivering 19,685 shares @ $1.92, valued at $37.8k
Exercised 39,251 restricted stock units @ $0
Granted 198,777 restricted stock units @ $0
Granted 397,554 options to buy @ $0
03/07/2023 4 Daly Jason B. (SVP, Chief Legal Officer) has filed a Form 4 on Amneal Pharmaceuticals, Inc.
Txns: Paid exercise price by delivering 8,164 shares @ $1.92, valued at $15.7k
Exercised 22,645 restricted stock units @ $0
Granted 152,905 restricted stock units @ $0
Granted 305,810 options to buy @ $0
03/02/2023 POSASR Form POSASR - Post-effective Amendment to an automatic shelf registration statement:
03/02/2023 POSASR Form POSASR - Post-effective Amendment to an automatic shelf registration statement:
  Next >>

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy